COMMUNIQUÉS West-GlobeNewswire
-
Sotera Health Announces Secondary Offering of Common Stock
04/03/2026 -
Actuate Therapeutics to Present at The Citizens Life Sciences Conference
04/03/2026 -
AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER
04/03/2026 -
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
04/03/2026 -
HealthRecon Connect Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
04/03/2026 -
Predictors of Success for 60-Day Peripheral Nerve Stimulation (PNS) Used for Treatment of Chronic Shoulder Pain: A Multi-Center Retrospective Chart Review
04/03/2026 -
Los Angeles Orthodontist McComb Orthodontics Reaches 5,000 Invisalign Cases, Earns Sapphire Status
04/03/2026 -
Coloplast appoints Gavin Wood as new CEO
04/03/2026 -
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M
04/03/2026 -
Baylor Genetics to Highlight New Data and Product Innovations at 2026 ACMG Annual Clinical Genetics Meeting
04/03/2026 -
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
04/03/2026 -
FemPulse Pivotal Study Selected For Presentation at the American Urological Association Annual Conference
04/03/2026 -
Koç University Hospital, a Koç Healthcare Institution, is Named Türkiye’s Top Hospital and Ranked Among the Newsweek–Statista World’s Best Hospitals 2026
04/03/2026 -
Compass Health Expands YGo Youth Mobile Crisis Services Across Northwest Washington
04/03/2026 -
Communiqué de presse : Dépôt d’un amendement au Document d’Enregistrement Universel 2025, contenant le Rapport Financier Annuel
04/03/2026 -
Press Release: Filing of an amendment to the French “Document d’Enregistrement Universel” containing the Annual Financial Report
04/03/2026 -
TLI Selects Higher Logic to Power Community Collaboration on the Autism Knowledge Gateway
04/03/2026 -
Boundless Bio to Participate in the Leerink Global Healthcare Conference
04/03/2026 -
Can-Fite’s Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study
04/03/2026
Pages